Abstract:Background: Methylprednisolone (MP) is a glucocorticoid steroid administered usually in severe sepsis and septic shock. However, the role and molecular mechanisms underlying hepatoprotective effect of MP in sepsis-induced acute liver injury (ALI) is largely unknown. The aim of the present study was to investigate the effect of MP in a mouse model of lipopolysaccharides (LPS)-induced ALI. Methods: A total of 96 male C57BL/6J mice were randomly divided into four groups (n=24 per group) according to the treatment including vehicle (control group) or LPS only (LPS group) or LPS with 2 mg/kg MP (LPS+2 mg/kg MP group) or LPS with 20 mg/kg MP (LPS+20 mg/kg MP group) three times at 1 h, 24 h, 48 h after LPS treatment. The livers and serum were collected for further analysis. Serum levels of total bilirubin (TBIL), total bile acid (TBA), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were measured at 24 h, 48 h or 72 h after LPS administration. Histological examinations were performed on liver, and liver sections were stained with hematoxylin & eosin (HE). Furthermore, the expression of Interleukin-6 (IL-6), Tumour Necrosis Factor-alpha (TNF-alpha), sodium-taurocholate co-transporting polypeptide (NTCP) and bile salt export pump (BSEP) in liver was analyzed by reverse transcription quantitative polymerase chain reaction (RT-qPCR) and western blot. Results: MP therapy protects mice against LPS-induced ALI at the dose of 2 mg/kg and 20 mg/kg. The serum TBIL, TBA, ALT, AST levels were significantly decreased in LPS+2 mg/kg MP group and LPS+20 mg/kg MP group compared with LPS group. However, there is no significant difference between the LPS+2 mg/kg MP group and the LPS+ 20 mg/kg MP group. Furthermore, LPS administration suppresses the expression of NTCP and BSEP, which is significantly reversed by MP therapy. Moreover, LPS-induced higher expression of IL-6 and TNF-a was significantly suppressed by MP administration. Conclusion: MP protects mice against LPS-induced ALI and improves bile acid secretion and transportation, partially due to the upregulated expression of NTCP and BSEP.

Malvidin Protects Against Lipopolysaccharide-Induced Acute Liver Injury in Mice Via Regulating Nrf2 and NLRP3 Pathways and Suppressing Apoptosis and Autophagy.

Malvidin alleviates LPS-induced septic intestinal injury through the nuclear factor erythroid 2-related factor 2/reactive oxygen species/NLRP3 inflammasome pathway

Malvidin promotes PGC-1α/Nrf2 signaling to attenuate the inflammatory response and restore mitochondrial activity in septic acute kidney injury

Malvidin alleviates mitochondrial dysfunction and ROS accumulation through activating AMPK-α/UCP2 axis, thereby resisting inflammation and apoptosis in SAE mice

Ameliorative effect of Malvidin on spleen injury in LPS‐induced sepsis

Α-Mangostin Suppresses NLRP3 Inflammasome Activation Via Promoting Autophagy in LPS-stimulated Murine Macrophages and Protects Against CLP-induced Sepsis in Mice

Tectorigenin Protects Against Experimental Fulminant Hepatic Failure by Regulating the TLR4/mitogen‐activated Protein Kinase and TLR4/nuclear Factor‐κb Pathways and Autophagy

Alanyl-Glutamine Protects against Lipopolysaccharide-Induced Liver Injury in Mice via Alleviating Oxidative Stress, Inhibiting Inflammation, and Regulating Autophagy

Plantamajoside Ameliorates Lipopolysaccharide-Induced Acute Lung Injury Via Suppressing NF-κB and MAPK Activation.

The effects of malvidin on oxidative stress parameters and inflammatory cytokines in LPS‐induced human THP‐1 cells

Isoliquiritigenin Alleviates LPS/ D-GalN-induced Acute Liver Failure by Activating the PGC-1α/ Nrf2 Pathway to Reduce Oxidative Stress and Inflammatory Response.

Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling.

Paeoniflorin ameliorates lipopolysaccharide‐induced acute liver injury by inhibiting oxidative stress and inflammation via SIRT1/FOXO1a/SOD2 signaling in rats

Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury Via NF-κB Signaling Pathway in Vivo and in Vitro

S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways

Thymol Alleviates LPS-Induced Liver Inflammation and Apoptosis by Inhibiting NLRP3 Inflammasome Activation and the AMPK-mTOR-Autophagy Pathway

Bacillus amyloliquefaciens SC06 Attenuated Lipopolysaccharide-Induced acute liver injury by suppressing bile acid-associated NLRP3 inflammasome activation

Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.

Gene knockout or inhibition of macrophage migration inhibitory factor alleviates lipopolysaccharide-induced liver injury via inhibiting inflammatory response

Glucocorticoids Alleviates Lipopolysaccharide-Induced Acute Liver Injury Associated With Promoting The Expression Of Ntcp And Bsep

Role of Α-Lipoic Acid in LPS/d-GalN Induced Fulminant Hepatic Failure in Mice: Studies on Oxidative Stress, Inflammation and Apoptosis.